Courtois G - Search Results

1

Down-regulation of NF-kappaB activity and NF-kappaB p65 subunit expression by ras and polyoma middle T oncogenes in human colonic Caco-2 cells.

Cadoret A, Bertrand F, Baron-Delage S, Lévy P, Courtois G, Gespach C, Capeau J, Cherqui G. Cadoret A, et al. Among authors: courtois g. Oncogene. 1997 Apr 3;14(13):1589-600. doi: 10.1038/sj.onc.1200992. Oncogene. 1997. PMID: 9129150

2

Mutations in the NF-kappaB signaling pathway: implications for human disease.

Courtois G, Gilmore TD. Courtois G, et al. Oncogene. 2006 Oct 30;25(51):6831-43. doi: 10.1038/sj.onc.1209939. Oncogene. 2006. PMID: 17072331 Review.

3

Posttranslational modifications of NEMO and its partners in NF-kappaB signaling.

Sebban H, Yamaoka S, Courtois G. Sebban H, et al. Among authors: courtois g. Trends Cell Biol. 2006 Nov;16(11):569-77. doi: 10.1016/j.tcb.2006.09.004. Epub 2006 Sep 20. Trends Cell Biol. 2006. PMID: 16987664 Review.

4

Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.

Sors A, Jean-Louis F, Pellet C, Laroche L, Dubertret L, Courtois G, Bachelez H, Michel L. Sors A, et al. Among authors: courtois g. Blood. 2006 Mar 15;107(6):2354-63. doi: 10.1182/blood-2005-06-2536. Epub 2005 Oct 11. Blood. 2006. PMID: 16219794 Free article.

5

Characterization of a mutant cell line that does not activate NF-kappaB in response to multiple stimuli.

Courtois G, Whiteside ST, Sibley CH, Israel A. Courtois G, et al. Mol Cell Biol. 1997 Mar;17(3):1441-9. doi: 10.1128/MCB.17.3.1441. Mol Cell Biol. 1997. PMID: 9032271 Free PMC article.

6

[Human pathologies associated with NF-kappaB defects].

Courtois G, Israël A. Courtois G, et al. J Soc Biol. 2004;198(2):93-6. J Soc Biol. 2004. PMID: 15368956 Review. French.

7

NF-kappaB-related genetic diseases.

Courtois G, Smahi A. Courtois G, et al. Cell Death Differ. 2006 May;13(5):843-51. doi: 10.1038/sj.cdd.4401841. Cell Death Differ. 2006. PMID: 16397577 Review.

8

NF-kappaB and inflammation in genetic disease.

Sebban H, Courtois G. Sebban H, et al. Among authors: courtois g. Biochem Pharmacol. 2006 Oct 30;72(9):1153-60. doi: 10.1016/j.bcp.2006.08.006. Epub 2006 Sep 11. Biochem Pharmacol. 2006. PMID: 16965764 Review.

9

The NF-kappaB signaling pathway in human genetic diseases.

Courtois G. Courtois G. Cell Mol Life Sci. 2005 Aug;62(15):1682-91. doi: 10.1007/s00018-005-5031-5. Cell Mol Life Sci. 2005. PMID: 15924263 Free PMC article. Review.

10

Inhibition of the NF-kappaB survival pathway via caspase-dependent cleavage of the IKK complex scaffold protein and NF-kappaB essential modulator NEMO.

Frelin C, Imbert V, Bottero V, Gonthier N, Samraj AK, Schulze-Osthoff K, Auberger P, Courtois G, Peyron JF. Frelin C, et al. Among authors: courtois g. Cell Death Differ. 2008 Jan;15(1):152-60. doi: 10.1038/sj.cdd.4402240. Epub 2007 Oct 12. Cell Death Differ. 2008. PMID: 17932497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters